Literature DB >> 15504759

A novel Na+ channel agonist, dimethyl lithospermate B, slows Na+ current inactivation and increases action potential duration in isolated rat ventricular myocytes.

Jin-Young Yoon1, Sung-Hun Ahn, Hyuncheol Oh, Young-Sup Kim, Shi Yong Ryu, Won-Kyung Ho, Suk-Ho Lee.   

Abstract

Voltage-gated Na(+) channel blockers have been widely used as local anaesthetics and antiarrhythmic agents. It has recently been proposed that Na(+) channel agonists can be used as inotropic agents. Here, we report the identification of a natural substance that acts as a Na(+) channel agonist. Using the patch-clamp technique in isolated rat ventricular myocytes, we investigated the electrophysiological effects of the substances isolated from the root extract of Salvia miltiorrhiza, which is known as 'Danshen' in Asian traditional medicine. By the intensive activity-guided fractionation, we identified dimethyl lithospermate B (dmLSB) as the most active component, while LSB, which is the major component of the extract, showed negligible electrophysiological effect. Action potential duration (APD(90)) was increased by 20 microM dmLSB from 58.8 +/- 12.1 to 202.3 +/- 9.5 ms. In spite of the prolonged APD, no early after-depolarization (EAD) was observed. dmLSB had no noticeable effect on K(+) or Ca(2+) currents, but selectively affected Na(+) currents (I(Na)). dmLSB slowed the inactivation kinetics of I(Na) by increasing the proportion of slowly inactivating component without inducing any persistent I(Na). The relative amplitude of slow component compared to the peak fast I(Na) was increased dose dependently by dmLSB (EC(50) = 20 microM). Voltage dependence of inactivation was not affected by dmLSB, while voltage dependence of activation shifted by 5 mV to the depolarised direction. Since the APD prolongation by dmLSB did not provoke EAD, which is thought as a possible mechanism for the proarrhythmia seen in other Na(+) channel agonists, dmLSB might be an excellent candidate for a Na(+) channel agonist. British Journal of Pharmacology (2004).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504759      PMCID: PMC1575928          DOI: 10.1038/sj.bjp.0705969

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins.

Authors:  Sho-Ya Wang; Ging Kuo Wang
Journal:  Cell Signal       Date:  2003-02       Impact factor: 4.315

2.  Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.

Authors:  D W Wang; N Makita; A Kitabatake; J R Balser; A L George
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

3.  Slowing of the inactivation of cardiac voltage-dependent sodium channels by the amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015).

Authors:  R Macianskiene; S Viappiani; K R Sipido; K Mubagwa
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

4.  Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.

Authors:  M W Veldkamp; P C Viswanathan; C Bezzina; A Baartscheer; A A Wilde; J R Balser
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

5.  Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.

Authors:  J Müller-Ehmsen; K Brixius; R H Schwinger
Journal:  J Cardiovasc Pharmacol       Date:  1998-05       Impact factor: 3.105

Review 6.  Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.

Authors:  W A Catterall
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

7.  Actions of pyrethroid insecticides on sodium currents, action potentials, and contractile rhythm in isolated mammalian ventricular myocytes and perfused hearts.

Authors:  C I Spencer; K H Yuill; J J Borg; J C Hancox; R Z Kozlowski
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

8.  Delayed treatment with lithospermate B attenuates experimental diabetic renal injury.

Authors:  Geun Taek Lee; Hunjoo Ha; Mankil Jung; Hari Li; Soon Won Hong; Bong Soo Cha; Hyun Chul Lee; Young Dong Cho
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

9.  Action potential changes associated with a slowed inactivation of cardiac voltage-gated sodium channels by KB130015.

Authors:  R Macianskiene; V Bito; L Raeymaekers; B Brandts; K R Sipido; K Mubagwa
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.

Authors:  Augustus O Grant; Michael P Carboni; Valentina Neplioueva; C Frank Starmer; Mirella Memmi; Carlo Napolitano; Silvia Priori
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

View more
  10 in total

Review 1.  A Na+ channel agonist: a potential cardiotonic agent with a novel mechanism?

Authors:  Masao Endoh
Journal:  Br J Pharmacol       Date:  2004-10-18       Impact factor: 8.739

2.  Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channel.

Authors:  Ajit Vikram; Christopher M Lewarchik; Jin-Young Yoon; Asma Naqvi; Santosh Kumar; Gina M Morgan; Julia S Jacobs; Qiuxia Li; Young-Rae Kim; Modar Kassan; Jing Liu; Mohanad Gabani; Ajay Kumar; Haider Mehdi; Xiaodong Zhu; Xiaoqun Guan; William Kutschke; Xiaoming Zhang; Ryan L Boudreau; Shengchuan Dai; Daniel S Matasic; Saet-Byel Jung; Kenneth B Margulies; Vikas Kumar; Markus M Bachschmid; Barry London; Kaikobad Irani
Journal:  Nat Med       Date:  2017-02-13       Impact factor: 53.440

3.  Fenpropathrin, a Widely Used Pesticide, Causes Dopaminergic Degeneration.

Authors:  Jing Xiong; Xiaowei Zhang; Jinsha Huang; Chunnuan Chen; Zhenzhen Chen; Ling Liu; Guoxin Zhang; Jiaolong Yang; Zhentao Zhang; Zhaohui Zhang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Mol Neurobiol       Date:  2015-01-10       Impact factor: 5.590

4.  Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome.

Authors:  Jeffrey M Fish; Daniel R Welchons; Young-Sup Kim; Suk-Ho Lee; Won-Kyung Ho; Charles Antzelevitch
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

5.  In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.

Authors:  M Iqbal Choudhary; Muniza Shaikh; Atia- Tul-Wahab; Atta- Ur-Rahman
Journal:  PLoS One       Date:  2020-07-24       Impact factor: 3.240

6.  Synthesis of a dual-labeled probe of dimethyl lithospermate B with photochemical and fluorescent properties.

Authors:  Eunyoung Lim; Jeremy Ricci; Mankil Jung
Journal:  Molecules       Date:  2011-11-28       Impact factor: 4.411

7.  Reversing Effect of Insulin on Local Anesthetics-Induced Sciatic Nerve Block in Rats.

Authors:  Jong Min Kim; Seok Hwa Choi
Journal:  Biomed Res Int       Date:  2019-03-11       Impact factor: 3.411

8.  Effects of mixed herbal extracts from parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix (KIOM-79) on cardiac ion channels and action potentials.

Authors:  Su Jung Park; Kwan Seok Choi; Dong Hoon Shin; Jin Sook Kim; Dae Sik Jang; Jae Beom Youm; Han Choe; Yung E Earm; Sung Joon Kim
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

9.  Cardiovascular effects of salvianolic Acid B.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

10.  Impaired Inactivation of L-Type Ca2+ Current as a Potential Mechanism for Variable Arrhythmogenic Liability of HERG K+ Channel Blocking Drugs.

Authors:  Jae Gon Kim; Dong Jun Sung; Hyun-ji Kim; Sang Woong Park; Kyung Jong Won; Bokyung Kim; Ho Chul Shin; Ki-Suk Kim; Chae Hun Leem; Yin Hua Zhang; Hana Cho; Young Min Bae
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.